SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- . (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results